Vedanta Phase II Data Position It To Chase Seres In C. Difficile Recurrence

 
• By Joseph Haas
  
Bacterias 3D rendering
Vedanta thinks its live biotherapeutic can prevent infection recurrence

More from Clinical Trials

More from R&D